Study details
Enrolling now
Nitrous Oxide Neuroimaging Trial
Keith M Vogt
NCT IDNCT06702631ClinicalTrials.gov data as of Apr 2026
Phase
EARLY_PHASE1
Target enrollment
60
Study length
about 1.4 years
Ages
18–59
Locations
1 site in PA
About this study
Researchers are testing the effects of nitrous oxide on memory and how it affects your body's response to pain. It uses imaging scans to see what happens in your brain during this process. The trial will last about 504 days, with two visits involved.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Nitrous oxide
- 2.Use Peripheral Nerve Stimulation
PhaseEARLY_Phase 1
DrugNitrous oxide
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low13%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
nitrous oxide (Inhaled anesthetic gas; causes analgesia and mild anesthesia)
Devices
therapeutic